rejoy-heath-logo
    • RejoyGPT
    • AI Scribe
    • AI Coder
    • AI Receptionist
    • AI Interpreter
    • Clinical Decision Support
    • Medical Search
  • Features
  • Pricing
Request a Demo

Products

  • RejoyGPT
  • AI Scribe
  • AI Coder
  • AI Receptionist
  • AI Interpreter
  • Clinical Decision Support
  • Medical Search
  • Features
  • Pricing
Request a Demo
rejoy-heath-logo
    • RejoyGPT
    • AI Scribe
    • AI Coder
    • AI Receptionist
    • AI Interpreter
    • Clinical Decision Support
    • Medical Search
  • Features
  • Pricing
Request a Demo

Products

  • RejoyGPT
  • AI Scribe
  • AI Coder
  • AI Receptionist
  • AI Interpreter
  • Clinical Decision Support
  • Medical Search
  • Features
  • Pricing
Request a Demo
rejoy-heath-logo
Company

The AI care team for clinics and hospitals. Scribe, coder, reception, interpretation, and clinical answers in one suite. You stay in charge.

Contact
Click here to
Contact Support
on WhatsApp

600 California St,

San Francisco, CA 94108

hello@rejoyhealth.com
AI care team
RejoyGPTAI ScribeAI CoderAI ReceptionistAI InterpreterClinical Decision SupportMedical Search
Resources
ResourcesQuestion BankContestsCommunityBlogSearch SymptomsSearch CalculatorsSearch DrugsSymptom CheckerPricing
Terms and conditions
Privacy policyTerms of Service
Published on November 18, 2026

Nationwide Recall Issued for Blood Pressure Medication Over Possible Metal Contamination

Now Hiring · Rejoy Health Team

We're hiring AI Trainers. Remote, contract, $75 to $100 +/hr.

Help train and evaluate the models behind Rejoy Health. No medical or technical background needed. If you write clearly in English, Spanish, French, or another language, we want to hear from you. Work remotely, on your own schedule.

View the role

A pharmaceutical company has announced a nationwide recall of a specific lot of prescription blood pressure medication following concerns that the capsules may contain metal particles. The potential contamination could pose a health risk to patients, prompting officials to advise consumers to stop using the affected medication and contact their healthcare providers.

Breckenridge Pharmaceutical, Inc. voluntarily recalled one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, distributed in 100-count bottles. The company announced the recall on November 16, 2026, after identifying a possible connection between the affected product and suspected metal contamination.

The recall applies to a particular lot rather than every propranolol product currently available. However, patients who take the medication are encouraged to check their prescriptions carefully to determine whether they have received the affected product.

Why Is the Propranolol Medication Being Recalled?

According to the company's announcement, the potential contamination involves metal particles that could have entered the manufacturing process.

Breckenridge Pharmaceutical explained that the recalled lot shared intermediate material suspected of being responsible for metal contamination identified in another lot. That separate lot was not released for commercial distribution.

Although the company has not confirmed that contaminated capsules reached consumers, the possibility of metal contamination was considered serious enough to warrant a voluntary nationwide recall.

Taking medication containing foreign metal particles could cause physical injuries, particularly if sharp fragments come into contact with the digestive system.

Company officials warned that consuming capsules from the affected lot could potentially cause cuts or injuries to soft tissues in the mouth, esophagus, stomach, or intestines.

Which Propranolol Medication Is Included in the Recall?

The recall specifically involves:

  • Medication: Propranolol Hydrochloride Extended-Release Capsules, USP
  • Strength: 60 mg
  • Packaging: Bottles containing 100 capsules
  • Manufacturer: Breckenridge Pharmaceutical, Inc.
  • Distribution: Nationwide
  • Distribution period: October 26 through November 4, 2026

The affected medication was distributed to wholesalers and pharmacies throughout the United States.

Consumers should examine their prescription packaging and contact their pharmacist if they are unsure whether their medication belongs to the recalled lot.

Importantly, brand-name equivalents such as Inderal LA and InnoPran XL are not included in this particular recall. These are separate commercial products and should not automatically be considered affected by the Breckenridge announcement.

What Is Propranolol Used to Treat?

Propranolol belongs to a class of medications known as beta blockers. These medicines work by reducing the effects of certain stress hormones, including adrenaline, on the heart and circulatory system.

By slowing the heart rate and reducing the workload on the heart, propranolol can help manage several medical conditions.

Healthcare professionals may prescribe the medication for:

  • High blood pressure, also known as hypertension.
  • Chest pain associated with angina.
  • Certain abnormal heart rhythms.
  • Migraine headache prevention.
  • Essential tremors.
  • Other cardiovascular and medical conditions.

Because propranolol is prescribed for different health conditions, abruptly interrupting treatment without medical guidance may create additional health concerns.

Patients taking the affected medication should therefore contact their healthcare providers promptly to discuss safe replacement options rather than simply stopping their treatment without arranging an alternative.

What Should Consumers Do if They Have the Recalled Medication?

Breckenridge Pharmaceutical is advising consumers to immediately stop using medication from the affected lot.

Anyone who believes they have received the recalled capsules should take the following precautions:

1. Check the prescription packaging.

Examine the medication label and available lot information. Contact the dispensing pharmacy if you cannot determine whether your prescription is included in the recall.

2. Stop taking the affected product.

Consumers should not continue using capsules from the recalled lot while waiting for further instructions.

3. Contact a healthcare professional.

Speak with your physician or pharmacist about replacement medication and how to maintain treatment safely. This is particularly important for patients taking propranolol for heart-related conditions.

4. Return unused medication.

The company advises consumers to return any unused portion of the affected product to the pharmacy where it was purchased.

5. Report possible health problems.

Anyone experiencing unusual symptoms after taking potentially affected medication should seek appropriate medical advice. Severe symptoms or suspected serious injury require urgent medical attention.

Breckenridge Pharmaceutical stated that it was not aware of any adverse events determined to be associated with the recall at the time of its announcement.

Another Recent Medication Recall Raises Concerns About Contamination

The propranolol recall follows another nationwide medication recall involving concerns about foreign particles in an injectable drug.

Last month, Par Health announced a voluntary recall of 22 lots of Argatroban Injection after foreign particulate matter was detected in the medication.

Argatroban is an anticoagulant, meaning it is used to prevent and treat blood clots. It is also used as an alternative to heparin for certain patients who cannot tolerate that medication.

Healthcare professionals may administer argatroban to patients who require blood clot prevention during medical procedures, including angioplasty and stent placement.

According to the FDA public health alert, the foreign particles identified in the affected injectable medication included cellulose, polystyrene, polyethylene terephthalate, stopper material, and potentially stainless steel.

The recalled products were distributed to wholesalers and hospitals nationwide between December 30, 2024, and May 5, 2025, according to the reported recall information.

Federal officials warned that administering an injection containing particulate matter could result in serious medical complications.

Potential consequences include pulmonary embolism, which occurs when a blood clot blocks blood flow in the lungs. Other possible complications include blockages in blood vessels, tissue damage, organ injury, and inflammation of vein walls that may contribute to clot formation.

The two recalls involve different medications and different types of contamination concerns. However, both highlight the importance of pharmaceutical quality controls and prompt action when potential manufacturing problems are identified.

Why Medication Recall Announcements Matter

Medication recalls are an important part of the pharmaceutical safety system. They help manufacturers, healthcare professionals, pharmacies, and regulators respond when a product may present a health risk.

Even when contamination has not been confirmed in every affected package, precautionary recalls can help prevent potentially harmful products from reaching additional patients.

Consumers should regularly pay attention to medication safety announcements, particularly when they take prescription drugs over an extended period.

Pharmacists can also help patients identify recalled products, check prescription details, and arrange suitable alternatives when necessary.

Patients should never assume that every medication containing the same active ingredient is automatically affected by a recall. Product names, manufacturers, strengths, packaging, and lot numbers can all determine whether a particular prescription is included.

For the latest information about the propranolol recall, consumers should consult the manufacturer's announcement and relevant FDA safety notices.

Sources

  1. Breckenridge Pharmaceutical, Inc., voluntary nationwide recall announcement, November 16, 2026.
  2. U.S. Food and Drug Administration (FDA), Par Health recall of Argatroban Injection due to the presence of particulate matter.
  3. NTD Health News, November 17, 2026.

Disclaimer

This article is intended for general informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Patients should consult a qualified healthcare professional before making changes to prescribed medication. Anyone who believes they have received a recalled product should contact their pharmacist or healthcare provider for guidance. Always refer to official manufacturer announcements and FDA notices for the most current recall information.

Now Hiring · Rejoy Health Team

Speak English, Spanish, or French? Get paid to train AI.

Rejoy Health is looking for AI Trainers to review model responses, write reference answers, and flag replies that are confusing or unhelpful. You will shape how millions of people receive health information, one careful judgement at a time. There is no degree, medical background, or coding experience required. If you can read and write well in English, Spanish, French, or another language, you can do this work. Remote and contract, $75 to $100+/hr, with hours that fit around study, work, or family commitments.

Apply today

Share this post

Explore Related Articles for Deeper Insights

Royal Bolton Hospital Introduces Temporary Face Mask Requirement as Winter Viruses Rise
Royal Bolton Hospital has brought back mandatory face masks in patient areas from Friday, October 30...
View article →
16 Children Hospitalised After Batteries Discovered Inside School Bake Sale Muffins in Germany
Sixteen primary school pupils were taken to hospital after potentially dangerous button batteries we...
View article →
Pakistani Teenager Killed in Lion Attack During TikTok Video Shoot at Lahore Breeding Farm
A tragic incident in Lahore, Pakistan, has raised serious concerns about wildlife safety, private ow...
View article →

To get more personalized answers,
download now

Login
Register